Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Nuclear Medicine Software Developed for Greater Productivity and Workflow Improvements

By MedImaging International staff writers
Posted on 06 Nov 2012
New nuclear medicine software provides enhanced integration and refined clinical content, for enhanced usability, workflow, and productivity.

Agfa HealthCare (Mortsel, Belgium) presented its the latest version of its Impax for Nuclear Medicine system at the 2012 Congress of the European Association of Nuclear Medicine (EANM) held in Milan (Italy), October 27-31, 2012. More...
The system provides the benefits of integrated care to the nuclear medicine department, thus supporting the patient’s entire exam flow. The new version offers optimized integration and refined in-depth clinical content, for improved usability, workflow, and productivity.

Impax for Nuclear Medicine fully integrates the department’s workflow, bringing together images and data from a wide range of modalities and departments into one information technology (IT) platform. Users can read, process, and report all nuclear medicine, single photon emission computed tomography (SPECT), positron emission tomography (PET), and multimodality images with only the push of a button, from a single workstation.

The system is built on one of the most advanced Picture Archiving and Communication Systems (PACS). “Impax for Nuclear Medicine continues to offer the nuclear medicine department all the benefits of integrated care, and in this advanced version of the solution we have further improved integration and clinical content,” noted Erik Gielen, EMEA business manager, Agfa HealthCare. “From start to finish, it supports the patient's complete exam flow, while also improving interdepartmental communication.”

“Oasis for Impax, one of the components of the Impax for Nuclear Medicine solution and developed in cooperation with Segami Corp., adds a fully featured nuclear medicine image processing and viewing platform to the Impax workstation,” said Dr. Léonne Prompers, nuclear medicine physician, University Hospital of Maastricht (the Netherlands). “We no longer have to switch between workstations, or manually synchronize patient study lists. We can now read and report all studies from the Impax workstation resulting in improved workflow and increased user convenience.”

Related Links:

Agfa HealthCare



New
Pocket Fetal Doppler
CONTEC10C/CL
Ultrasound Table
Women’s Ultrasound EA Table
New
Mobile X-Ray Machine
MARS 15 / 30
Radiology Software
DxWorks
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to MedImaging.net and get access to news and events that shape the world of Radiology.
  • Free digital version edition of Medical Imaging International sent by email on regular basis
  • Free print version of Medical Imaging International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of Medical Imaging International in digital format
  • Free Medical Imaging International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Radiography

view channel
Image: AI can identify “mammographically-visible” types of interval cancers earlier by flagging them at the time of screening (Photo courtesy of ScreenPoint Medical)

AI Improves Early Detection of Interval Breast Cancers

Interval breast cancers, which occur between routine screenings, are easier to treat when detected earlier. Early detection can reduce the need for aggressive treatments and improve the chances of better outcomes.... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.